E00.2 Congenital iodine-deficiency syndrome, mixed type

Name of the Condition

• Congenital Iodine-Deficiency Syndrome, Mixed Type (ICD-10 Code: E00.2)

Summary

Congenital iodine-deficiency syndrome, mixed type, is a condition resulting from insufficient iodine intake during pregnancy, leading to thyroid hormone deficiency in the fetus. This affects both neurological and physical development, combining features of the neurological and myxedematous types. Early intervention is critical to mitigate long-term effects.

Causes

The syndrome is caused by inadequate maternal iodine intake, which disrupts fetal thyroid hormone production. Iodine is essential for thyroid function, and deficiency during pregnancy impairs the developing fetus's ability to produce these hormones, leading to congenital hypothyroidism with mixed manifestations.

Risk Factors

• Maternal iodine deficiency during pregnancy.
• Living in regions with low dietary iodine (e.g., areas with limited access to iodized salt).
• Poor nutritional status or limited dietary diversity in pregnant individuals.

Symptoms

• Severe developmental delays, including intellectual disability.
• Myxedematous features, such as skin thickening and facial swelling.
• Growth retardation and short stature.
• Hearing loss or speech impairments.
• Muscle weakness or hypotonia.
• Thyroid enlargement (goiter) in some cases.

Diagnosis

Diagnosis involves newborn screening for thyroid hormone levels, typically measuring thyroid-stimulating hormone (TSH) and thyroxine (T4). Confirmatory tests may include thyroid ultrasound or further endocrine evaluation to assess the extent of deficiency and associated manifestations.

Treatment Options

Treatment focuses on lifelong thyroid hormone replacement therapy to normalize hormone levels. Early initiation is essential to support neurological and physical development. Regular monitoring of thyroid function and growth parameters is required to adjust therapy as needed.

Prognosis and Follow-Up

Prognosis depends on the timeliness of diagnosis and treatment. With early intervention, many individuals achieve normal development, though some may experience residual deficits. Long-term follow-up includes regular thyroid function testing, developmental assessments, and monitoring for growth or cognitive delays.

Complications

• Persistent intellectual disability or developmental delays.
• Growth retardation or short stature.
• Hearing or speech impairments.
• Myxedematous features that may require ongoing management.
• Increased risk of other thyroid-related disorders later in life.

Lifestyle & Prevention

• Ensure adequate iodine intake during pregnancy through iodized salt or supplements.
• Consume a balanced diet with iodine-rich foods (e.g., seafood, dairy).
• Avoid regions with known iodine deficiency without proper supplementation.
• Regular prenatal care to monitor nutritional status.

When to Seek Professional Help

Seek immediate medical attention if a newborn shows signs of poor feeding, lethargy, jaundice, or abnormal growth. For pregnant individuals, consult a healthcare provider if experiencing symptoms of iodine deficiency (e.g., goiter, fatigue) or living in an iodine-deficient area.

Tips for Medical Coders

Document the presence of both neurological and myxedematous features to support the mixed type classification. Include details on maternal iodine intake, newborn screening results, and any confirmatory tests. Ensure documentation aligns with the clinical manifestations to justify the E00.2 code.